Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis

Journal of the American Heart Association

Volumn 5, Issue 11, 2016, Pages

  Pilgrim, Thomas ^a   Stortecky, Stefan ^a   Nietlispach, Fabian ^b   Heg, Dik ^c   Tueller, David ^d   Toggweiler, Stefan ^e   Ferrari, Enrico ^f,g   Noble, Stephane ^h   Maisano, Francesco ^b   Jeger, Raban ⁱ   Roffi, Marco ^h   Grünenfelder, Jürg ^j   Huber, Christoph ^a   Wenaweser, Peter ^a,k   Windecker, Stephan ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d TRIEMLI HOSPITAL   (Switzerland)

^e LUZERNER KANTONSSPITAL   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g DIVISION OF CARDIOLOGY   (Switzerland)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^j Neuro Zentrum Hirslanden Klinik   (Switzerland)

^k KLINIK IM PARK   (Switzerland)

more..

Author keywords

Aortic valve regurgitation; Newer generation devices; Permanent pacemaker; Transcatheter aortic valve replacement

Indexed keywords

AGED; AORTIC REGURGITATION; AORTIC STENOSIS; ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGISTER; SAFETY; SWITZERLAND; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; AORTIC VALVE STENOSIS; COHORT ANALYSIS; COMPARATIVE STUDY; DEVICES; HEART VALVE PROSTHESIS; POSTOPERATIVE COMPLICATION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTHESIS DESIGN;

AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; COHORT STUDIES; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; SWITZERLAND; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85017528488     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.004088     Document Type: Article

References (22)

1. Pilgrim T, Windecker S. Newer-generation devices for transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2016;9:373-375.
2. Meredith AM IT, Walters DL, Dumonteil N, Worthley SG, Tch-etche D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Allocco DJ, Dawkins KD. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014;64:1339-1348.
3. Rampat R, Khawaja MZ, Byrne J, MacCarthy P, Blackman DJ, Krishnamurthy A, Gunarathne A, Kovac J, Banning A, Kharbanda R, Firoozi S, Brecker S, Redwood S, Bapat V, Mullen M, Aggarwal S, Manoharan G, Spence MS, Khogali S, Dooley M, Cockburn J, de Belder A, Trivedi U, Hildick-Smith D. Transcatheter aortic valve replacement using the repositionable LOTUS valve. JACC Cardiovasc Interv. 2016;9:367-372.
4. Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchetche D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Feldman TE, Allocco DJ, Dawkins KD. 1-year outcomes with the fully repositionable and retrievable Lotus Transcatheter Aortic Replacement Valve in 120 high-risk surgical patients with severe aortic stenosis. JACC Cardiovasc Interv. 2016;9:376-384.
5. Wenaweser P, Stortecky S, Heg D, Tueller D, Nietlispach F, Falk V, Pedrazzini G, Jeger R, Reuthebuch O, Carrel T,Räber L,AmannFW, Ferrari E, Toggweiler S, Noble S, Roffi M, Gruenenfelder J, Jüni P, Windecker S, Huber C. Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry. EuroIntervention. 2014;10:982-989.
6. Tchetche D, Van Mieghem NM. New-generation TAVI devices: description and specifications. EuroIntervention. 2014;10(suppl U):U90-U100.
7. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es G-A, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438-1454.
8. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695.
9. Ludman PF, Moat N, de Belder MA, Blackman DJ, Duncan A, Banya W, MacCarthy PA, Cunningham D, Wendler O, Marlee D, Hildick-Smith D, Young CP, Kovac J, Uren NG, Spyt T, Trivedi U, Howell J, Gray H; UK TAVI Steering Committee and the National Institute for Cardiovascular Outcomes Research. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation. 2015;131:1181-1190.
10. Abdel-Wahab M, Comberg T, Büttner HJ, El-Mawardy M, Chatani K, Gick M, Geist V, Richardt G, Neumann F-J; Segeberg-Krozingen TAVI Registry. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. JACC Cardiovasc Interv. 2014;7:284-292.
11. Binder RK, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Pedrazzini G, Amann FW, Ferrari E, Noble S, Nietlispach F, Maisano F, Räber L, Roffi M, Grünenfelder J, Jüni P, Huber C, Windecker S, Wenaweser P. Procedural results and clinical outcomes of transcatheter aortic valve implantation in Switzerland: an observational cohort study of Sapien 3 versus Sapien XT transcatheter heart valves. Circ Cardiovasc Interv. 2015;8:e002653.
12. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P, Pilgrim T, Gloekler S, Khattab AA, Huber C, Carrel T, Eberle B, Meier B, Boekstegers P, Jüni P, Gerckens U, Grube E, Windecker S. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;60:493-501.
13. Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S, Babaliaros V, Herrmann HC, Szeto WY, Jilaihawi H, Fearon WF, Tuzcu EM, Pichard AD, Makkar R, Williams M, Hahn RT, Xu K, Smith CR, Leon MB, Kodali SK; PARTNER Publications Office. Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart. 2015;101: 1665-1671.
14. Nazif TM, Dizon JM, Hahn RT, Xu K, Babaliaros V, Douglas PS, El-Chami MF, Herrmann HC, Mack M, Makkar RR, Miller DC, Pichard A, Tuzcu EM, Szeto WY, Webb JG, Moses JW, Smith CR, Williams MR, Leon MB, Kodali SK. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2015;8:60- 69.
15. Van der Boon RMA, Van Mieghem NM, Theuns DA, Nuis R-J, Nauta ST, Serruys PW, Jordaens L, van Domburg RT, de Jaegere PPT. Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. Int J Cardiol. 2013;168:1269-1273.
16. Walther T, Hamm CW, Schuler G, Berkowitsch A, Kötting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck K-H, Mohr FW, Möllmann H; GARY Executive Board. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol. 2015;65:2173-2180.
17. Mack MJ, Brennan JM, Brindis R, Carroll J, Edwards F, Grover F, Shahian D, Tuzcu EM, Peterson ED, Rumsfeld JS, Hewitt K, Shewan C, Michaels J, Christensen B, Christian A, O'Brien S, Holmes D; STS/ACC TVT Registry. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310:2069-2077.
18. Holmes DR, Brennan JM, Rumsfeld JS, Dai D, O'Brien SM, Vemulapalli S, Edwards FH, Carroll J, Shahian D, Grover F, Tuzcu EM, Peterson ED, Brindis RG, Mack MJ. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313:1019.
19. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D'Agostino RB, Leon MB. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016. Available at: http://linkinghub.elsevier.com/retrieve/pii/S0140673616300733. Accessed April 23, 2016.
20. Bijuklic K, Haselbach T, Witt J, Krause K, Hansen L, Gehrckens R, Rie F-C, Schofer J. Increased risk of cerebral embolization after implantation of a balloon-expandable aortic valve without prior balloon valvuloplasty. JACC Cardiovasc Interv. 2015;8:1608-1613.
21. Liao Y, Meng Y, Zhao Z, Zuo Z, Li Y, Xiong T, Cao J, Xu Y, Feng Y, Chen M. Metaanalysis of the effectiveness and safety of transcatheter aortic valve implantation without balloon predilation. Am J Cardiol. 2016. Available at: http://linkinghub.elsevier. com/retrieve/pii/S000291491630296X. Accessed April 23, 2016.
22. Stortecky S, Windecker S, Pilgrim T, Heg D, Buellesfeld L, Khattab AA, Huber C, Gloekler S, Nietlispach F, Mattle H, Jüni P, Wenaweser P. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. EuroIntervention. 2012;8:62-70.